Figure 2From: Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class receivedPredictors of time to undetectable HIV RNA (< 500 copies/ml). HAART: highly active antiretroviral therapy, IVDU: intravenous drug users, NNRTI: non-nucleoside reverse transcriptase inhibitor, PI/r: protease inhibitors boosted by ritonavir, PI: protease inhibitors not boosted by ritonavir.Back to article page